Samsung Biologics, One Careful Step

Today I finally picked up some Samsung Biologics. The business itself is rock solid, growth engine humming along, but the catch is the price, the market already knows how good it is so it's not exactly a bargain right now, and the industry carries enough swing factors that I kept the bet modest. KB Financial and SK Telecom are still just watchlist names for me, nothing's flashing a clear enough signal to actually step in yet. Everything else I'm holding stays untouched today, the broader market's sitting in a wait-and-see mood so I saw no reason to move.